Koyfin Home > Directory > Health Care > Aduro Biotech > Long-Term Debt

Aduro Biotech Long-Term Debt Chart (ADRO)

Aduro Biotech annual/quarterly Long-Term Debt from 2013 to 2014.
  • Aduro Biotech Long-Term Debt for the quarter ending September 09, 2014 was $1m
  • Aduro Biotech Long-Term Debt for the last 12 months ending September 09, 2014 was $1m
  • Aduro Biotech Annual Long-Term Debt for 2013 was $1m a -305.41% decrease of -4m from 2012
  • Aduro Biotech Annual Long-Term Debt for 2012 was $6m
Other Cash Flow Metrics:
  • Aduro Biotech Cash Flow from Operations for the quarter ending December 12, 2018 was $-1m a -1,784.81% increase of 20m year over year
  • Aduro Biotech Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-23m a 36.84% decrease of -8m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Long-Term Debt Data

09/2014$1m
12/2013$1m

Annual ADRO Long-Term Debt Data

2013$1m
2012$6m